US 8,202,258

Application 10/571,314 · Granted Jun 19, 2012

Plastic needle and devices comprising it

Estimated expiration

August 24, 2027

276 days remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2003011211: Resource not found (404)
Earliest effective filing
Sep 11, 2003
+ 20 years
Sep 11, 2023
PTA +1443d
Aug 24, 2027
No TD
—
Final
Aug 24, 2027

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 9, 2006
Earliest effective filing
September 11, 2003
Issue date
June 19, 2012
PTA
+1443 days
Base expiry (before PTA)
September 11, 2023

September 11, 2003 + 20 years = September 11, 2023 + 1443 PTA days = August 24, 2027

  • National stage entry of application PCTEP2003011211, filed Sep 11, 2003

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 10/571,314 · US 8,202,258

PatentReply compiles the prosecution history behind US 8,202,258: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8202258

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.